Sandoz drugs Jubbonti and Wyost are approved for use in all indications covered by the Amgen products, Prolia and Xgeva. But no launch date is planned yet, due to ongoing patent litigation between the two companies.
Missing a bone? A Chinese startup’s got a fix for you – it uses 3D bioprinting to build implantable bones, and is preparing to enter human trials, 3dprint reports. The company’s now looking for investors to help hasten its path to the market – since human trials are underway and will continue into June. This kind of […]
In an interview, Kyan Health Co-Founder and Chief Commercial Officer Konstantin Struck discussed how Kyan gives mid-market and enterprise employers access to premium workforce mental healthcare, at a price point that is affordable.